106 related articles for article (PubMed ID: 2856207)
1. Vaccine induced HSV 1 antibodies fail to correlate with protection against HSV 2 in guinea pigs.
Welch MJ; Ridgeway PH; Phillpotts RJ
FEMS Microbiol Immunol; 1988 Dec; 1(3):157-62. PubMed ID: 2856207
[TBL] [Abstract][Full Text] [Related]
2. Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs.
Hook LM; Cairns TM; Awasthi S; Brooks BD; Ditto NT; Eisenberg RJ; Cohen GH; Friedman HM
PLoS Pathog; 2018 May; 14(5):e1007095. PubMed ID: 29791513
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of HSV-1 ISCOM vaccine in the guinea-pig model of HSV-2 infection.
Erturk M; Phillpotts RJ; Welch MJ; Jennings R
Vaccine; 1991 Oct; 9(10):728-34. PubMed ID: 1661978
[TBL] [Abstract][Full Text] [Related]
4. Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein D.
Berman PW; Gregory T; Crase D; Lasky LA
Science; 1985 Mar; 227(4693):1490-2. PubMed ID: 2983428
[TBL] [Abstract][Full Text] [Related]
5. Antibody reactivity with Skinner HSV vaccine.
Muniu EM; Durham J; Shariff D; Hartley CE; Fuller A; Melling J; Wiblin C; Wilkins G; Buchan A; Skinner GR
Med Microbiol Immunol; 1987; 176(6):315-27. PubMed ID: 2828898
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes.
Stanberry LR; Bernstein DI; Burke RL; Pachl C; Myers MG
J Infect Dis; 1987 May; 155(5):914-20. PubMed ID: 3031173
[TBL] [Abstract][Full Text] [Related]
7. Use of herpes simplex virus (HSV) type 1 ISCOMS 703 vaccine for prophylactic and therapeutic treatment of primary and recurrent HSV-2 infection in guinea pigs.
Simms JR; Heath AW; Jennings R
J Infect Dis; 2000 Apr; 181(4):1240-8. PubMed ID: 10762560
[TBL] [Abstract][Full Text] [Related]
8. Recombinant interleukin 2 as an adjuvant for vaccine-induced protection. Immunization of guinea pigs with herpes simplex virus subunit vaccines.
Weinberg A; Merigan TC
J Immunol; 1988 Jan; 140(1):294-9. PubMed ID: 2826591
[TBL] [Abstract][Full Text] [Related]
9. Protection and serum antibody responses in guinea-pigs and mice immunized with HSV-1 antigen preparations obtained using different detergents.
Ertürk M; Welch MJ; Phillpotts RJ; Jennings R
Vaccine; 1989 Oct; 7(5):431-6. PubMed ID: 2554607
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus genital infection of the female guinea pig as a model for the evaluation of an experimental vaccine.
Thornton B; Baskerville A; Bailey NE; Melling JM; Hambleton P
Vaccine; 1984 Jun; 2(2):141-8. PubMed ID: 6099646
[TBL] [Abstract][Full Text] [Related]
11. Preparation and efficacy of antiherpes type 1 and 2 subunit vaccines.
Kavaklova L; Dundarov S; Andonov P; Bakalov B; Dundarova D; Brodvarova I
Acta Virol; 1986 Sep; 30(5):402-10. PubMed ID: 2878588
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of a herpes simplex subunit vaccine.
Cappel R; Sprecher S; De Cuyper F; De Braekeleer J
J Med Virol; 1985 Jun; 16(2):137-45. PubMed ID: 2989419
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs.
Bernard MC; Barban V; Pradezynski F; de Montfort A; Ryall R; Caillet C; Londono-Hayes P
PLoS One; 2015; 10(4):e0121518. PubMed ID: 25837802
[TBL] [Abstract][Full Text] [Related]
14. A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens.
Awasthi S; Mahairas GG; Shaw CE; Huang ML; Koelle DM; Posavad C; Corey L; Friedman HM
J Virol; 2015 Aug; 89(16):8497-509. PubMed ID: 26041292
[TBL] [Abstract][Full Text] [Related]
15. Immune response to a DNA free herpes simplex vaccine in man.
Cappel R; Sprecher S; Rickaert F; de Cuyper F
Arch Virol; 1982; 73(1):61-7. PubMed ID: 6289778
[TBL] [Abstract][Full Text] [Related]
16. Native herpes simplex virus glycoprotein D vaccine: immunogenicity and protection in animal models.
Mishkin EM; Fahey JR; Kino Y; Klein RJ; Abramovitz AS; Mento SJ
Vaccine; 1991 Mar; 9(3):147-53. PubMed ID: 1645898
[TBL] [Abstract][Full Text] [Related]
17. Complement-requiring neutralizing antibody in guinea pigs with primary and recurrent genital herpes.
Zheng ZM; Hsiung GD
Proc Soc Exp Biol Med; 1984 Nov; 177(2):332-6. PubMed ID: 6091148
[TBL] [Abstract][Full Text] [Related]
18. Antibody to herpes simplex virus (HSV) ICP-35 proteins after HSV challenge of animals immunized with HSV subunit vaccines.
Bernstein DI; Stanberry LR; Kappes JC; Burke RL; Myers MG
J Infect Dis; 1988 Jun; 157(6):1178-86. PubMed ID: 2836519
[TBL] [Abstract][Full Text] [Related]
19. A test for the relative potency of herpes simplex virus vaccines based upon the female guinea-pig model of HSV 2 genital infection.
Phillpotts RJ; Welch MJ; Ridgeway PH; Walkland AC; Melling J
J Biol Stand; 1988 Apr; 16(2):109-18. PubMed ID: 2836425
[TBL] [Abstract][Full Text] [Related]
20. Limited antibody-dependent cellular cytotoxicity antibody response induced by a herpes simplex virus type 2 subunit vaccine.
Kohl S; Charlebois ED; Sigouroudinia M; Goldbeck C; Hartog K; Sekulovich RE; Langenberg AG; Burke RL
J Infect Dis; 2000 Jan; 181(1):335-9. PubMed ID: 10608784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]